WuXi Vaccines
www.wuxibiologics.comWuXi Vaccines, a subsidiary of WuXi Biologics, focuses on human vaccine discovery, development and manufacture. An exciting new addition to the WuXi Biologics family, WuXi Vaccines will bring to the global vaccine industry the world-class integrated platforms and CDMO business model on which WuXi Biologics reputation is based. We provide an integrated global CDMO platform for vaccine development and manufacturing for global clients. In Dundalk, Ireland we are constructing a world class integrated vaccine manufacturing facility, which will include drug substance manufacturing (DS), drug product manufacturing (DP), Manufacturing Science and Technology Labs (MS&T) as well as Quality Control labs (QC), dedicated to manufacturing our partner’s vaccine products for the global market.
Read moreWuXi Vaccines, a subsidiary of WuXi Biologics, focuses on human vaccine discovery, development and manufacture. An exciting new addition to the WuXi Biologics family, WuXi Vaccines will bring to the global vaccine industry the world-class integrated platforms and CDMO business model on which WuXi Biologics reputation is based. We provide an integrated global CDMO platform for vaccine development and manufacturing for global clients. In Dundalk, Ireland we are constructing a world class integrated vaccine manufacturing facility, which will include drug substance manufacturing (DS), drug product manufacturing (DP), Manufacturing Science and Technology Labs (MS&T) as well as Quality Control labs (QC), dedicated to manufacturing our partner’s vaccine products for the global market.
Read moreCountry
City (Headquarters)
Shanghai
Industry
Founded
2018
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Board Member
Email ****** @****.comPhone (***) ****-****Facilities Management Site Lead
Email ****** @****.comPhone (***) ****-****Procurement Manager
Email ****** @****.comPhone (***) ****-****Black Utilities Manager
Email ****** @****.comPhone (***) ****-****
Technologies
(38)